Genetically Predicted Circulating C-Reactive Protein Concentration and Colorectal Cancer Survival: A Mendelian Randomization Consortium Study

Xinwei Hua; James Y. Dai; Sara Lindström; Tabitha A. Harrison; Yi Lin; Steven R. Alberts; Elizabeth Alwers; Sonja I. Berndt; Hermann Brenner; Daniel D. Buchanan; Peter T. Campbell; Graham Casey; Jenny Chang‐Claude; Steven Gallinger; Graham G. Giles; Richard M. Goldberg; Marc J. Gunter; Michael Hoffmeister; Mark A. Jenkins; Amit D. Joshi; Wenjie Ma; Roger L. Milne; Neil Murphy; Rish K. Pai; Lori C. Sakoda; Robert E. Schoen; Qian Shi; Martha L. Slattery; Mingyang Song; Emily White; Loı̈c Le Marchand; Andrew T. Chan; Ulrike Peters; Polly A. Newcomb

doi:10.1158/1055-9965.epi-20-1848

Abstract

This is the authors' abstract. We don't add key points for this paper.

Future research evaluating genetically determined levels of other circulating inflammatory biomarkers (i.e., IL6) with colorectal cancer survival outcomes is needed.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hua et al. (2021) studied this question.

synapsesocial.com/papers/69d75a71086f9d6299f309fd https://doi.org/10.1158/1055-9965.epi-20-1848

View Full Paper

Ask AI

Bookmark

Share

Genetically Predicted Circulating C-Reactive Protein Concentration and Colorectal Cancer Survival: A Mendelian Randomization Consortium Study

Abstract

Ask about this paper

Discussion

Cite This Study

Genetically Predicted Circulating C-Reactive Protein Concentration and Colorectal Cancer Survival: A Mendelian Randomization Consortium Study

Abstract

Ask about this paper

Discussion

Cite This Study

Keep reading

Keep reading